Page 16 - Teddy Whiley News Today

ANGLE plc: Angle PLC Announces Exercise of options and total voting rights GUILDFORD, SURREY / ACCESSWIRE / May 19, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 216,000 new Ordinary shares of £0.10 each ("New Ordinary Shares") in the Company. The New Ordinary Shares rank pari passu with the existing Ordinary shares in the Company. An application has been made to the London S...

About ANGLE plc www.angleplc.com ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLEs proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.   ANGLEs cell separation technology is called the Parsortix ®   system, and it enables a liquid biopsy (a simp...

About ANGLE plc   www.angleplc.com   ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLEs proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.   ANGLEs cell separation technology is called the Parsortix ® system, and it enables a liquid biopsy (a simple blood ...

Re-opening Update Revolution Bars Group plc ("the Group" or "the Company"), a leading operator of 66 premium bars, trading under the Revolution and Revolucion de Cuba brands, welcomes the comments by the Prime Minister, Boris Johnson on England, further easing restrictions to allow indoor trading of our bars on 17 May 2021 and confirming that the Roadmap remains on track for a return to restriction free trading on 21 June 2021. 13 April 2021, the Company was excited to be able to recommence...

ANGLE plc: Angle PLC Announces Exercise of Options and Total Voting Rights SURREY, UK / ACCESSWIRE / April 30, 2021 / ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 203,333 new Ordinary shares of £0.10 each ("New Ordinary Shares") in the Company. The New Ordinary Shares rank pari passu with the existing Ordinary shares in the Company. An application has been made to the London Stock...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

Investegate announcements from Angle PLC, Exercise of options and total voting rights

ANGLE plc ("ANGLE" or "the Company") Preliminary Results for the year ended 31 December 2020 FDA SUBSTANTIVE REVIEW PROGRESSING LAUNCH OF CLINICAL LABORATORY SERVICES FIRST LARGE-SCALE CONTRACT WITH

      ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, today announces audited preliminary results for the year ended 31 December 2020.     · Full De Novo Submission made in September 2020 for US Food and Drug Administration (FDA) clearance of the Parsortix ® system for capturing and harvesting circulating tumour cells from metastatic breast cancer patients -  FDA Administrative Review complete and Substantive Revi...

Investegate announcements from Avacta Group PLC, Issue of Equity